Industry-Sponsored Learning Session - Labcorp Presents: Test. Better. Enhanced NIPT reporting for patients with positive results
Jan. 28, 2021 2:30 - 3:30pm
Test. Better. With the
marked increase in the use of cell-free DNA screening (cfDNA/NIPT) in clinical
practice, many NIPT innovations were introduced as screening technology rapidly
expanded over the past decade. But which NIPT innovations are likely to tangibly
improve outcomes for your practice and patients? Which NIPT innovations improve
test performance and bolster confidence knowing a screening result is reliable?
This session will present a new bioinformatics metric which will support counseling for patients with positive results. Using real-world case studies, we will discuss enhancements to test reporting and how these improvements impact the positive predictive value associated with the result. This comprehensive, evidenced-based session will help you: Test. Better.
Key Takeaways:
Thomas Westover, MD FACOG
Chair of the New Jersey Section of the American College of Obstetrics & Gynecology, President of the NJ OBGYN Society, Co-Chair of the New Jersey Hospital Association Statewide Perinatal Safety Collaborative, Chief of Maternal Fetal Medicine at Capital Health System in Trenton, NJ and Associate Professor of MFM and OBGYN at Cooper Medical School Rowan University in Camden, NJ. He serves as a member of several NJ Dept of Health Committees and assists the NJ legislature on matters related to women's health and family health.
Jill Rafalko, MS, CGC, LGC
Medical Science Liaison, Integrated Genetics, is a board certified and licensed genetic counselor. Before joining Integrated Genetics, she worked as a prenatal genetic counselor for 8 years at New Jersey Perinatal Associates at Saint Barnabas Medical Center in Livingston, NJ. She completed her genetic counseling training at Mount Sinai School of Medicine.
This session will present a new bioinformatics metric which will support counseling for patients with positive results. Using real-world case studies, we will discuss enhancements to test reporting and how these improvements impact the positive predictive value associated with the result. This comprehensive, evidenced-based session will help you: Test. Better.
Key Takeaways:
- Examine how a new NIPT laboratory reporting metric influences positive predictive value
- Explore how these NIPT enhancements can support patient counseling
- Apply real world case studies to demonstrate
how this new reporting metric can bring clarity to NIPT results
Thomas Westover, MD FACOG
Chair of the New Jersey Section of the American College of Obstetrics & Gynecology, President of the NJ OBGYN Society, Co-Chair of the New Jersey Hospital Association Statewide Perinatal Safety Collaborative, Chief of Maternal Fetal Medicine at Capital Health System in Trenton, NJ and Associate Professor of MFM and OBGYN at Cooper Medical School Rowan University in Camden, NJ. He serves as a member of several NJ Dept of Health Committees and assists the NJ legislature on matters related to women's health and family health.
Jill Rafalko, MS, CGC, LGC
Medical Science Liaison, Integrated Genetics, is a board certified and licensed genetic counselor. Before joining Integrated Genetics, she worked as a prenatal genetic counselor for 8 years at New Jersey Perinatal Associates at Saint Barnabas Medical Center in Livingston, NJ. She completed her genetic counseling training at Mount Sinai School of Medicine.
Price: $0.00